参考文献/References:
[1].Niccoli G,Scalone G,Lerman A,et al. Coronary microvascular obstruction in acute myocardial infarction[J]. Eur Heart J,2016,37(13):1024-1033.
[2].Gavara J,Rodriguez-Palomares JF,Valente F,et al.Prognostic value of strain by tissue tracking cardiac magnetic resonance after ST-segment elevation myocardial infarction[J]. JACC Cardiovasc Imaging,2018,11(10):1448-1457.
[3].de Waha S,Patel MR,Granger CB,et al. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction:an individual patient data pooled analysis from seven randomized trials[J].Eur Heart J,2017,38(47):3502-3510.
[4].Menees DS,Peterson ED,Wang Y,et al. Door-to-balloon time and mortality among patients undergoing primary PCI[J]. N Engl J Med,2013,369(10):901-909.
[5].潘华福,叶少武.急性心肌梗死患者经皮冠脉介入术中无复流的研究进展[J].心血管病学进展,2018,39(6):1029-1034.
[6].Bodi V,Monmeneu JV,Ortiz-Perez JT,et al.Prediction of reverse remodeling at cardiac MR imaging soon after first ST-segment-elevation myocardial infarction:results of a large prospective registry[J]. Radiology,2016,278(1):54-63.
[7].Carrick D,Haig C,Ahmed N,et al. Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-segment elevation myocardial infarction:pathophysiological insights and clinical implications[J]. J Am Heart Assoc,2016,5(2):e002834.
[8].Herring N,Tapoulal N,Kalla M,et al. Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction[J]. Eur H eart J,2019,40(24):1920-1929.
[9].Stakos DA,Kambas K,Konstantinidis T,et al. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction[J].Eur Heart J,2015,36(22):1405-1414.
[10].Yoshino S,Cilluffo R,Best PJ,et al. Single nucleotide polymorphisms associated with abnormal coronary microvascular function[J].Coron Artery Dis,2014,25(4):281-289.
[11].Galiuto L,Garramone B,Scara` A,et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indices of post-infarct reperfusion in predicting left ventricular remodeling:results of the multicenter AMICI study[J]. J Am Coll Cardiol,2008,51(5):552-559.
[12].Niccoli G,Montone RA,Ibanez B,et al.Optimized treatment of ST-elevation myocardial infarction[J]. Circ Res,2019,125(2):245-258.
[13].García-Prieto J,Villena-Gutiérrez R,Gómez M,et al.Neutrophil stunning by metoprolol reduces infarct size[J]. Nat Commun,2017,8:14780.
[14].Ibanez B,James S,Agewall S,et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J].Eur Heart J,2018,39(2):119-177.
[15].Berwanger O,Santucci EV,de Barros E Silva PGM,et al.Effect of loading dose of atorvastatin prior to planned percutaneous coronary intervention on major adverse cardiovascular events in acute coronary syndrome:the SECURE-PCI randomized clinical trial[J].JAMA,2018,319(13):1331-1340.
[16].Mendieta G,Ben-Aicha S,Gutiérrez M,et al.Intravenous statin administration during myocardial infarction compared with oral post-infarct administration[J]. J Am Coll Cardiol,2020,75(12):1386-1420.
[17].Hu K,Wang X,Hu H,et al.Intracoronary application of nicorandil regulates the inflammatory response induced by percutaneous coronary intervention[J]. J Cell M ol Med,2020,24(8):4863-4870.
[18].Pi SF,Liu YW,Li T,et al. Effect of sequential nicorandil on myocardial microcirculation and short-term prognosis in acute myocardial infarction patients undergoing coronary intervention[J].J Thorac Dis,2019,11(3):744-752.
[19].Chen GX,Wang HN,Zou JL,et al. Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI[J]. World J Emerg Med,2020,11(3):157-163.
[20].Niccoli G,Spaziani C,Crea F,et al.Left ventricular remodeling and 1-year clinical follow-up of the REOPEN-AMI trial[J]. J Am Coll Cardiol,2014,63(14):1454-1455.
[21].Nazir SA,McCann GP,Greenwood JP,et al. Strategies to attenuate micro-vascular obstruction during P-PCI:the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial[J]. Eur Heart J,2016,37(24):1910-1919.
[22].Chen W,Spitzl A,Mathes D,et al.Endothelial actions of ANP enhance myocardial inflammatory infiltration in the early phase after acute infarction[J]. Circ Res,2016,119(2):237–248.
[23].Costa RA,Abizaid A,Lotan C,et al. Impact of thrombus burden on outcomes after standard versus mesh-covered stents in acute myocardial infarction(from the MGuard for acute ST elevation reperfusion trial)[J]. Am J Cardiol,2015,115(2):161 -166.
[24].Heusch G. Cardioprotection research must leave its comfort zone[J]. Eur Heart J,2018,39(36):3393-3395.
[25].Stiermaier T,Jensen JO,Rommel KP,et al.Combined intrahospital remote ischemic perconditioning and postconditioning improves clinical outcome in ST-elevation myocardial infarction:long-term results of the LIPSIA CONDITIONING trial[J]. Circ Res,2019,124(10):1482-1491.
[26].Davidson SM,Ferdinandy P,Andreadou I,et al.Multitarget strategies to reduce myocardial ischemia/reperfusion injury:JACC review topic of the week[J]. J Am Coll Cardiol,2019,73(1):89-99.
[27].Rios-Navarro C,Hueso L,Mi?ana G,et al. Coronary serum obtained after myocardial infarction induces angiogenesis and microvascular obstruction repair. Role of hypoxia-inducible factor-1A[J]. Rev Esp Cardiol,2018,71(6):440-449.
[28].Ferraro B,Leoni G,Hinkel R,et al. Pro-angiogenic macrophage phenotype to promote myocardial repair[J]. J Am Coll Cardiol,2019,73(23):2990-3002.
[29].Hueso L,Rios-Navarro C,Ruiz-Sauri A,et al.Dynamics and implications of circulating anti-angiogenic VEGF-A165b isoform in patients with ST-segment elevation myocardial infarction[J]. Sci Rep,2017,7(1):9962.
相似文献/References:
[1]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(9):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[2]赵劲东,综述,董平栓,等.合并多支血管病变的急性ST段抬高型心肌梗死介入术治疗策略的研究进展[J].心血管病学进展,2016,(3):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
ZHAO Jindong,DONG Pingshuan.Research Progress of Interventional Therapy in Patients with ST-elevation
Myocardial Infarction and Multivessel Disease[J].Advances in Cardiovascular Diseases,2016,(9):295.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.021]
[3]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(9):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[4]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(9):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[5]陆鑫 张华.无载体含药物洗脱支架研究进展1[J].心血管病学进展,2019,(7):1032.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.017]
LU xinZHANG Hua.Polymer-free Drug-eluting Stent[J].Advances in Cardiovascular Diseases,2019,(9):1032.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.017]
[6]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(9):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[7]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(9):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
[8]刘丹丹 王海珠 任凤波.ST段抬高型心肌梗死PCI术后血浆微囊泡浓度对再次血运重建的风险预测分析[J].心血管病学进展,2019,(7):1056.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.023]
LIU Dandan,WANG Haizhu,REN Fengbo.Predictive analysis of plasma microvesicles concentration in patients with ST-segment elevation myocardial infarction after target lesion revascularization[J].Advances in Cardiovascular Diseases,2019,(9):1056.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.023]
[9]杨颜瑜,苏星,谭敏,等.炎症指标与急性心肌梗死研究进展[J].心血管病学进展,2019,(6):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
YANG Yanyu,SU Xing,TAN Min,et al.Relationship Between Inflammation Index and Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(9):947.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.027]
[10]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(9):726.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
[11]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(9):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[12]潘甜 马康华.急性心肌梗死经皮冠脉介入术后冠状动脉无复流的预防和治疗进展[J].心血管病学进展,2019,(5):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]
PAN Tian,MA Kanghua.Prevention and Treatment of Coronary Artery No-Reflow after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(9):730.[doi:10.16806/j.cnki.issn.1004-3932019.05.017]